Overview

Significance of Mesothelin Expression Positive in Diseases

Non-Small Cell Lung Carcinoma +

Malignant Solid Tumor +

Ovarian Carcinoma +

Pleural Mesothelioma +

Breast Carcinoma +

Fallopian Tube Carcinoma +

Hepatocellular Carcinoma +

Lung Adenocarcinoma +

Mesothelioma +

Pancreatic Adenocarcinoma +

Pancreatic Carcinoma +

Peritoneal Mesothelioma +

Primary Peritoneal Carcinoma +

Cancer +

Cholangiocarcinoma +

Esophageal Carcinoma +

Gastric Carcinoma +

Glioblastoma +

Malignant Ovarian Epithelial Tumor +

Malignant Pleural Mesothelioma +

Ovarian Serous Adenocarcinoma +

Pancreatic Ductal Adenocarcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20171026. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.